Latest ABG-WTT Global Life Science Capital Partners GP Lt Stock Portfolio
About ABG-WTT Global Life Science Capital Partners GP Lt and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, ABG-WTT Global Life Science Capital Partners GP Ltd reported an equity portfolio of $20.1 Millions as of 30 Sep, 2024.
The top stock holdings of ABG-WTT Global Life Science Capital Partners GP Ltd are , RPID, LUNG. The fund has invested 92.9% of it's portfolio in CG ONCOLOGY INC and 4.6% of portfolio in RAPID MICRO BIOSYSTEMS INC.
They significantly reduced their stock positions in CG ONCOLOGY INC.
New Buys
No new stocks were added by ABG-WTT Global Life Science Capital Partners GP Lt
Additions
No additions were made to existing positions by ABG-WTT Global Life Science Capital Partners GP Lt
Reductions
Ticker
% Reduced
cg oncology inc
-45.87
ABG-WTT Global Life Science Capital Partners GP Lt reduced stake in above stock
Sold off
None of the stocks were completely sold off by ABG-WTT Global Life Science Capital Partners GP Lt
ABG-WTT Global Life Science Capital Partners GP Lt Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of ABG-WTT Global Life Science Capital Partners GP Lt